D Korchagina

Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group

Sandra Nestler-Parr, D Korchagina, Mondher Toumi et al. · Value in Health · 2018 · 133 citations · Full text

Disease Diagnosis, Epidemiology, Engineering +12

Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe

Goran Medić, D Korchagina, Katherine Eve Young et al. · Journal of Market Access & Health Policy · 2017 · 39 citations · Full text

Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study

Irene Lenoir‐Wijnkoop, Dan Merenstein, D Korchagina et al. · Frontiers in Pharmacology · 2019 · 34 citations · Full text

Determinants of orphan drugs prices in France: a regression analysis

D Korchagina, A. Millier, A.L. Vataire et al. · Orphanet Journal of Rare Diseases · 2017 · 20 citations · Full text

Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France

C. Chouaïd, N. Germain, Gérard de Pouvourville et al. · Current Medical Research and Opinion · 2019 · 18 citations · Full text